GenMark Diagnostics Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017
October 19 2017 - 3:47PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it
plans to release its third quarter earnings results after market
close on Thursday, November 2, 2017. Management will hold a
conference call to review the Company's financial performance
starting at 4:30 p.m. ET on the same day. The conference call will
be concurrently webcast. The link to the webcast will be available
on the GenMark Diagnostics, Inc. website at www.genmarkdx.com under
the investor relations section and will be archived for future
reference. To listen to the conference call, please dial (877)
312-5847 (US/Canada) or (253) 237-1154 (International) and use the
conference ID number 89238764 approximately five minutes prior to
the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
multiplex molecular diagnostic solutions designed to enhance
patient care, improve key quality metrics, and reduce the total
cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® and ePlex® systems are designed
to support a broad range of molecular diagnostic tests with
compact, easy-to-use workstations and self-contained, disposable
test cartridges. GenMark’s ePlex: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address
a broad range of infectious disease testing needs, including
respiratory, bloodstream, and gastrointestinal infections. For more
information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171019006468/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident/Chief Executive
Officer760-448-4325
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Aug 2024 to Sep 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Sep 2023 to Sep 2024